us > Maine > Oxford > Gilead > Latest & Local News
Gilead news
Gilead Sciences, Inc. $GILD Shares Sold by Holocene Advisors LP - MarketBeat
Gilead Sciences, Inc. $GILD Shares Sold by Holocene Advisors LP MarketBeat
📢 Published on 📅 16 March 2026 🕒 10:54 am
Gotham Asset Management LLC Has $38.40 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gotham Asset Management LLC Has $38.40 Million Position in Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 16 March 2026 🕒 10:46 am
Crawford Investment Counsel Inc. Decreases Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Crawford Investment Counsel Inc. Decreases Stock Position in Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 16 March 2026 🕒 9:21 am
Gilead Sciences, Inc. (GILD): Growth Prospects Backed by Analyst Upgrades - Insider Monkey
Gilead Sciences, Inc. (GILD): Growth Prospects Backed by Analyst Upgrades Insider Monkey
📢 Published on 📅 15 March 2026 🕒 9:56 pm
Tyler Robinette Obituary (1965 - 2026) - Mt. Gilead, OH - Crawford County Now - Legacy obituary
Tyler Robinette Obituary (1965 - 2026) - Mt. Gilead, OH - Crawford County Now Legacy obituary
📢 Published on 📅 15 March 2026 🕒 6:50 pm
Capitolis Liquid Global Markets LLC Invests $40.40 Million in Gilead Sciences, Inc. $GILD - MarketBeat
Capitolis Liquid Global Markets LLC Invests $40.40 Million in Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 15 March 2026 🕒 10:49 am
Calydon Capital Has $7.34 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
Calydon Capital Has $7.34 Million Position in Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 15 March 2026 🕒 10:39 am
Chevy Chase Trust Holdings LLC Has $70.93 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
Chevy Chase Trust Holdings LLC Has $70.93 Million Position in Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 15 March 2026 🕒 10:19 am
BNP Paribas Has $7.71 Million Stake in Gilead Sciences, Inc. $GILD - MarketBeat
BNP Paribas Has $7.71 Million Stake in Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 15 March 2026 🕒 9:24 am
Banco Bilbao Vizcaya Argentaria S.A. Grows Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Banco Bilbao Vizcaya Argentaria S.A. Grows Stock Holdings in Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 15 March 2026 🕒 8:26 am
Ameriprise Financial Inc. Buys 400,002 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Ameriprise Financial Inc. Buys 400,002 Shares of Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 15 March 2026 🕒 7:54 am
Alliancebernstein L.P. Sells 258,213 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Alliancebernstein L.P. Sells 258,213 Shares of Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 15 March 2026 🕒 7:54 am
Wellington Management Group LLP Has $2.84 Billion Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Wellington Management Group LLP Has $2.84 Billion Holdings in Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 14 March 2026 🕒 12:09 pm
Gilead Sciences, Inc. $GILD Shares Sold by Prudential PLC - MarketBeat
Gilead Sciences, Inc. $GILD Shares Sold by Prudential PLC MarketBeat
📢 Published on 📅 14 March 2026 🕒 10:40 am
Dodge & Cox Trims Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Dodge & Cox Trims Stock Position in Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 14 March 2026 🕒 8:12 am
Gilead Sciences (NASDAQ:GILD) Upgraded at Wall Street Zen - MarketBeat
Gilead Sciences (NASDAQ:GILD) Upgraded at Wall Street Zen MarketBeat
📢 Published on 📅 14 March 2026 🕒 6:45 am
'Manufacturing is access': How Gilead's early production moves set PrEP med Yeztugo up for success - Fierce Pharma
'Manufacturing is access': How Gilead's early production moves set PrEP med Yeztugo up for success Fierce Pharma
📢 Published on 📅 13 March 2026 🕒 2:33 pm
Martingale Asset Management L P Decreases Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Martingale Asset Management L P Decreases Stock Holdings in Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 13 March 2026 🕒 10:54 am
Invesco Ltd. Purchases 1,618,453 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Invesco Ltd. Purchases 1,618,453 Shares of Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 13 March 2026 🕒 10:53 am
Fredericktown FFA attends the Mt. Gilead CDE Invitational - Your Ohio News
Fredericktown FFA attends the Mt. Gilead CDE Invitational Your Ohio News
📢 Published on 📅 12 March 2026 🕒 2:12 pm
Assessing Gilead Sciences (GILD) Valuation After Recent Share Price Momentum And Mixed Fair Value Signals - simplywall.st
Assessing Gilead Sciences (GILD) Valuation After Recent Share Price Momentum And Mixed Fair Value Signals simplywall.st
📢 Published on 📅 12 March 2026 🕒 1:37 pm
Gilead Sciences, Inc. $GILD Stake Boosted by SageView Advisory Group LLC - MarketBeat
Gilead Sciences, Inc. $GILD Stake Boosted by SageView Advisory Group LLC MarketBeat
📢 Published on 📅 12 March 2026 🕒 10:45 am
Franklin Resources Inc. Decreases Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Franklin Resources Inc. Decreases Stake in Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 12 March 2026 🕒 10:37 am
Bokf Na Raises Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Bokf Na Raises Stock Position in Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 12 March 2026 🕒 8:39 am
Photo 1 in the Mt. Gilead @ Fredericktown Photo Gallery (118 Photos) - MaxPreps.com
Photo 1 in the Mt. Gilead @ Fredericktown Photo Gallery (118 Photos) MaxPreps.com
📢 Published on 📅 12 March 2026 🕒 7:00 am
2 Recession-Resistant Dividend Stocks to Buy Now - The Motley Fool
2 Recession-Resistant Dividend Stocks to Buy Now The Motley Fool
📢 Published on 📅 11 March 2026 🕒 11:00 am
Magnetar Financial LLC Increases Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Magnetar Financial LLC Increases Stock Position in Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 11 March 2026 🕒 10:53 am
British Land and Royal London Asset Management announce letting to Gilead Sciences at One Triton Square, Regent’s Place - British Land
📢 Published on 📅 11 March 2026 🕒 7:05 am
Jefferies Initiates Coverage on Gilead Sciences (GILD) with 'Buy' Rating | GILD Stock News - GuruFocus
Jefferies Initiates Coverage on Gilead Sciences (GILD) with 'Buy' Rating | GILD Stock News GuruFocus
📢 Published on 📅 10 March 2026 🕒 2:42 pm
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street’s Latest Biopharma Calls Explained - Yahoo Finance
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street’s Latest Biopharma Calls Explained Yahoo Finance
📢 Published on 📅 10 March 2026 🕒 2:38 pm
What 16 Analyst Ratings Have To Say About Gilead Sciences - Benzinga
What 16 Analyst Ratings Have To Say About Gilead Sciences Benzinga
📢 Published on 📅 10 March 2026 🕒 2:01 pm
Gilead Sciences (NASDAQ:GILD) Now Covered by Analysts at Jefferies Financial Group - MarketBeat
Gilead Sciences (NASDAQ:GILD) Now Covered by Analysts at Jefferies Financial Group MarketBeat
📢 Published on 📅 10 March 2026 🕒 1:22 pm
Gilead Sciences, Inc. $GILD Holdings Trimmed by Capital World Investors - MarketBeat
Gilead Sciences, Inc. $GILD Holdings Trimmed by Capital World Investors MarketBeat
📢 Published on 📅 10 March 2026 🕒 11:43 am
Capital International Inc. CA Raises Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Capital International Inc. CA Raises Stock Holdings in Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 10 March 2026 🕒 11:29 am
Legal & General Group Plc Buys 414,454 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Legal & General Group Plc Buys 414,454 Shares of Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 10 March 2026 🕒 11:15 am
Russell Investments Group Ltd. Sells 49,215 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Russell Investments Group Ltd. Sells 49,215 Shares of Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 10 March 2026 🕒 10:45 am
Fieldview Capital Management LLC Invests $1.91 Million in Gilead Sciences, Inc. $GILD - MarketBeat
Fieldview Capital Management LLC Invests $1.91 Million in Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 10 March 2026 🕒 10:45 am
GILEAD SCIENCES INC (NASDAQ:GILD): A Durable Dividend Stock for Income Investors - ChartMill
GILEAD SCIENCES INC (NASDAQ:GILD): A Durable Dividend Stock for Income Investors ChartMill
📢 Published on 📅 10 March 2026 🕒 10:41 am
Jefferies initiates Gilead Sciences stock with buy rating - Investing.com
Jefferies initiates Gilead Sciences stock with buy rating Investing.com
📢 Published on 📅 10 March 2026 🕒 10:37 am
Gilead to Acquire Arcellx, Inc. (ACLX) for Up to $7.8 billion - Yahoo Finance
Gilead to Acquire Arcellx, Inc. (ACLX) for Up to $7.8 billion Yahoo Finance
📢 Published on 📅 10 March 2026 🕒 7:35 am
Banque Cantonale Vaudoise Has $8.91 Million Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Banque Cantonale Vaudoise Has $8.91 Million Holdings in Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 10 March 2026 🕒 7:30 am
Gilead Sciences (GILD) Outperforms Broader Market: What You Need to Know - Yahoo Finance Singapore
Gilead Sciences (GILD) Outperforms Broader Market: What You Need to Know Yahoo Finance Singapore
📢 Published on 📅 9 March 2026 🕒 9:50 pm
The Handmaid's Tale sequel series The Testaments opens up 'another part of Gilead' - empireonline.com
The Handmaid's Tale sequel series The Testaments opens up 'another part of Gilead' empireonline.com
📢 Published on 📅 9 March 2026 🕒 2:03 pm
6-car crash on I-71 NB near Mt. Gilead sends one to hospital - WSYX
6-car crash on I-71 NB near Mt. Gilead sends one to hospital WSYX
📢 Published on 📅 8 March 2026 🕒 10:04 pm
Is It Time To Reassess Gilead Sciences (GILD) After Its Strong Share Price Run - Yahoo Finance
Is It Time To Reassess Gilead Sciences (GILD) After Its Strong Share Price Run Yahoo Finance
📢 Published on 📅 7 March 2026 🕒 11:13 pm
Growing Up Gilead: How ‘The Testaments’ Brings a “Beautiful Darkness” to ‘The Handmaid’s Tale’ Universe (Exclusive) - The Hollywood Reporter
Growing Up Gilead: How ‘The Testaments’ Brings a “Beautiful Darkness” to ‘The Handmaid’s Tale’ Universe (Exclusive) The Hollywood Reporter
📢 Published on 📅 5 March 2026 🕒 8:00 am
South Africa seeks local production of Gilead's HIV prevention drug - Reuters
South Africa seeks local production of Gilead's HIV prevention drug Reuters
📢 Published on 📅 4 March 2026 🕒 8:00 am
Gilead Sciences Arcellx Deal Deepens Oncology Bet And Tests HIV Reliance - Yahoo Finance
Gilead Sciences Arcellx Deal Deepens Oncology Bet And Tests HIV Reliance Yahoo Finance
📢 Published on 📅 2 March 2026 🕒 8:00 am
Gilead Foundation Awards $12 Million to Empower Community Health Workers and Expand HIV Prevention Initiatives Across 14 States and the District of Columbia - Business Wire
📢 Published on 📅 2 March 2026 🕒 8:00 am
Assessing Gilead Sciences (GILD) Valuation As Recent Share Price Momentum Meets Conflicting Fair Value Signals - Yahoo Finance
Assessing Gilead Sciences (GILD) Valuation As Recent Share Price Momentum Meets Conflicting Fair Value Signals Yahoo Finance
📢 Published on 📅 28 February 2026 🕒 8:00 am
Gilead's experimental HIV treatment shows low discontinuation rates in studies - Reuters
Gilead's experimental HIV treatment shows low discontinuation rates in studies Reuters
📢 Published on 📅 25 February 2026 🕒 8:00 am
Gilead paints clearer picture of next-gen HIV tablet's prowess with results from 2 late-stage studies - Fierce Pharma
Gilead paints clearer picture of next-gen HIV tablet's prowess with results from 2 late-stage studies Fierce Pharma
📢 Published on 📅 25 February 2026 🕒 8:00 am
Gilead Sciences Enters $7.8 Billion Definitive Agreement to Acquire Arcellx - Pharmaceutical Executive
Gilead Sciences Enters $7.8 Billion Definitive Agreement to Acquire Arcellx Pharmaceutical Executive
📢 Published on 📅 23 February 2026 🕒 4:14 pm
Gilead Sciences to Acquire Arcellx to Maximize Long-term Potential of Anito-cel - Business Wire
Gilead Sciences to Acquire Arcellx to Maximize Long-term Potential of Anito-cel Business Wire
📢 Published on 📅 23 February 2026 🕒 8:00 am
Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion - Reuters
Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion Reuters
📢 Published on 📅 23 February 2026 🕒 8:00 am
Gilead Sciences to Present at Upcoming Investor Conferences - Business Wire
Gilead Sciences to Present at Upcoming Investor Conferences Business Wire
📢 Published on 📅 23 February 2026 🕒 8:00 am
Gilead Doubles Down on CAR T With $7.8B Arcellx Acquisition - BioSpace
Gilead Doubles Down on CAR T With $7.8B Arcellx Acquisition BioSpace
📢 Published on 📅 23 February 2026 🕒 8:00 am
Gilead to Acquire Arcellx for $7.8B, Adding Anito-Cel to Cancer Pipeline - GEN - Genetic Engineering and Biotechnology News
Gilead to Acquire Arcellx for $7.8B, Adding Anito-Cel to Cancer Pipeline GEN - Genetic Engineering and Biotechnology News
📢 Published on 📅 23 February 2026 🕒 8:00 am
Gilead Sciences to Buy Arcellx in Deal Valued at $7.8 Billion - WSJ
Gilead Sciences to Buy Arcellx in Deal Valued at $7.8 Billion WSJ
📢 Published on 📅 23 February 2026 🕒 8:00 am
Gilead to buy cancer therapy developer Arcellx for up to $7.8 billion - Reuters
Gilead to buy cancer therapy developer Arcellx for up to $7.8 billion Reuters
📢 Published on 📅 23 February 2026 🕒 8:00 am
Gilead to buy Arcellx in nearly $8B deal - statnews.com
Gilead to buy Arcellx in nearly $8B deal statnews.com
📢 Published on 📅 23 February 2026 🕒 8:00 am
Gilead Sciences to Acquire Arcellx to Maximize Long-Term Potential of Anito-cel - Business Wire
Gilead Sciences to Acquire Arcellx to Maximize Long-Term Potential of Anito-cel Business Wire
📢 Published on 📅 23 February 2026 🕒 8:00 am
Gilead to buy cancer drug developer Arcellx for up to $7.8bn - Financial Times
Gilead to buy cancer drug developer Arcellx for up to $7.8bn Financial Times
📢 Published on 📅 23 February 2026 🕒 8:00 am
Gilead to buy Arcellx in $7.8B wager on multiple myeloma cell therapy - BioPharma Dive
Gilead to buy Arcellx in $7.8B wager on multiple myeloma cell therapy BioPharma Dive
📢 Published on 📅 23 February 2026 🕒 8:00 am
Gilead to Present New HIV Treatment and Prevention Data at CROI 2026, With a Focus on Expanding Options - Business Wire
Gilead to Present New HIV Treatment and Prevention Data at CROI 2026, With a Focus on Expanding Options Business Wire
📢 Published on 📅 17 February 2026 🕒 8:00 am
Gilead's latest synthetic lethal therapy comes via $1.5B deal with China's Genhouse - Fierce Biotech
Gilead's latest synthetic lethal therapy comes via $1.5B deal with China's Genhouse Fierce Biotech
📢 Published on 📅 16 February 2026 🕒 8:00 am
Gilead 2026 outlook short of Wall Street view, shares dip - Reuters
Gilead 2026 outlook short of Wall Street view, shares dip Reuters
📢 Published on 📅 11 February 2026 🕒 8:00 am
‘Pieces are coming together’ amid Gilead's Yeztugo launch: exec - Fierce Pharma
‘Pieces are coming together’ amid Gilead's Yeztugo launch: exec Fierce Pharma
📢 Published on 📅 11 February 2026 🕒 8:00 am
Gilead Sciences Announces Fourth Quarter and Full Year 2025 Financial Results - Business Wire
Gilead Sciences Announces Fourth Quarter and Full Year 2025 Financial Results Business Wire
📢 Published on 📅 10 February 2026 🕒 8:00 am
Earnings Preview: Gilead Sciences (GILD) Q4 Earnings Expected to Decline - Yahoo Finance
Earnings Preview: Gilead Sciences (GILD) Q4 Earnings Expected to Decline Yahoo Finance
📢 Published on 📅 3 February 2026 🕒 8:00 am
Gilead Sciences to Release Fourth Quarter & Full Year 2025 Financial Results on Tuesday, February 10, 2026 - Yahoo Finance
Gilead Sciences to Release Fourth Quarter & Full Year 2025 Financial Results on Tuesday, February 10, 2026 Yahoo Finance
📢 Published on 📅 27 January 2026 🕒 8:00 am
Gilead Sciences (GILD) Is Up 11.0% After Trodelvy Combo Outperforms Keytruda Chemo In Phase 3 Trial - Has The Bull Case Changed? - Yahoo Finance
📢 Published on 📅 27 January 2026 🕒 8:00 am
Why Gilead Sciences (GILD) Outpaced the Stock Market Today - Yahoo Finance
Why Gilead Sciences (GILD) Outpaced the Stock Market Today Yahoo Finance
📢 Published on 📅 22 January 2026 🕒 8:00 am
JPM26: As lenacapavir momentum builds, Gilead eyes new deals from a 'position of strength' - Fierce Biotech
JPM26: As lenacapavir momentum builds, Gilead eyes new deals from a 'position of strength' Fierce Biotech
📢 Published on 📅 14 January 2026 🕒 8:00 am
JPM26: HIV pipeline dosing optionality gives Gilead advantage - Clinical Trials Arena
JPM26: HIV pipeline dosing optionality gives Gilead advantage Clinical Trials Arena
📢 Published on 📅 13 January 2026 🕒 8:00 am
Gilead's new HIV prevention shot added to CVS's drug coverage lists, CEO says - Reuters
Gilead's new HIV prevention shot added to CVS's drug coverage lists, CEO says Reuters
📢 Published on 📅 12 January 2026 🕒 8:00 am
The Bull Case For Gilead Sciences (GILD) Could Change Following New OncoNano Drug-Delivery Collaboration - Yahoo Finance
The Bull Case For Gilead Sciences (GILD) Could Change Following New OncoNano Drug-Delivery Collaboration Yahoo Finance
📢 Published on 📅 11 January 2026 🕒 8:00 am
Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication - Fierce Biotech
Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication Fierce Biotech
📢 Published on 📅 7 January 2026 🕒 8:00 am
Gilead Keeps Dealing With $300M OncoNano Drug Delivery Cancer Pact - BioSpace
Gilead Keeps Dealing With $300M OncoNano Drug Delivery Cancer Pact BioSpace
📢 Published on 📅 6 January 2026 🕒 8:00 am
Gilead garners lipid package for cancer asset in $300M research pact - Fierce Biotech
Gilead garners lipid package for cancer asset in $300M research pact Fierce Biotech
📢 Published on 📅 6 January 2026 🕒 8:00 am
Morgan Stanley Expects Gilead Sciences (GILD) to Thrive as Biopharma Policy Uncertainties Fade in 2026 - Yahoo Finance
Morgan Stanley Expects Gilead Sciences (GILD) to Thrive as Biopharma Policy Uncertainties Fade in 2026 Yahoo Finance
📢 Published on 📅 31 December 2025 🕒 8:00 am
Gilead Sciences to acquire Repare’s RP-3467 - Pharmaceutical Technology
Gilead Sciences to acquire Repare’s RP-3467 Pharmaceutical Technology
📢 Published on 📅 26 December 2025 🕒 8:00 am
Gilead pays $35M to license pair of HSV assets from Assembly Bio pact - Fierce Biotech
Gilead pays $35M to license pair of HSV assets from Assembly Bio pact Fierce Biotech
📢 Published on 📅 22 December 2025 🕒 8:00 am
Does Gilead Still Offer Value After Its 2025 Surge and Pipeline Progress? - Yahoo Finance
Does Gilead Still Offer Value After Its 2025 Surge and Pipeline Progress? Yahoo Finance
📢 Published on 📅 17 December 2025 🕒 8:00 am
Gilead’s investigational single-tablet regimen of bictegravir and lenacapavir for HIV treatment meets primary endpoint in Phase 3 ARTISTRY-2 trial - European AIDS Treatment Group
Gilead’s investigational single-tablet regimen of bictegravir and lenacapavir for HIV treatment meets primary endpoint in Phase 3 ARTISTRY-2 trial European AIDS Treatment Group
📢 Published on 📅 15 December 2025 🕒 10:57 pm
Gilead builds case for new HIV pill with second positive Phase III study - FirstWord Pharma
Gilead builds case for new HIV pill with second positive Phase III study FirstWord Pharma
📢 Published on 📅 15 December 2025 🕒 8:00 am
Arcus discontinues Gilead-partnered TIGIT trials due to futility - Fierce Biotech
Arcus discontinues Gilead-partnered TIGIT trials due to futility Fierce Biotech
📢 Published on 📅 12 December 2025 🕒 8:00 am
Gilead hatches $400M biobucks deal for Swedish biotech's TREX1 cancer program - Fierce Biotech
Gilead hatches $400M biobucks deal for Swedish biotech's TREX1 cancer program Fierce Biotech
📢 Published on 📅 24 November 2025 🕒 8:00 am
Gilead and GLAAD Partner for a Powerful Virtual Dialogue During Transgender Awareness Week - GLAAD
Gilead and GLAAD Partner for a Powerful Virtual Dialogue During Transgender Awareness Week GLAAD
📢 Published on 📅 19 November 2025 🕒 8:00 am
Neglected & Emerging Viruses and Pandemic Preparedness | Gilead Sciences - Gilead Sciences
Neglected & Emerging Viruses and Pandemic Preparedness | Gilead Sciences Gilead Sciences
📢 Published on 📅 7 November 2025 🕒 6:46 am
Gilead to present data on potential first weekly oral treatment for HIV - Clinical Trials Arena
Gilead to present data on potential first weekly oral treatment for HIV Clinical Trials Arena
📢 Published on 📅 15 October 2025 🕒 7:00 am
Global biotech leaders Amgen and Gilead announcing expansions in California, the #1 state for life sciences - California State Portal | CA.gov
Global biotech leaders Amgen and Gilead announcing expansions in California, the #1 state for life sciences California State Portal | CA.gov
📢 Published on 📅 15 September 2025 🕒 7:00 am
Gilead beats whistleblower lawsuit over hepatitis C drugs - Reuters
Gilead beats whistleblower lawsuit over hepatitis C drugs Reuters
📢 Published on 📅 12 September 2025 🕒 7:00 am
Gilead Sciences Commits to Veeva Vault CRM - Veeva
Gilead Sciences Commits to Veeva Vault CRM Veeva
📢 Published on 📅 10 September 2025 🕒 7:00 am
Gilead Price Hikes Screw ADAP Programs, HIV Patients--AHF Protest - AIDS Healthcare Foundation
Gilead Price Hikes Screw ADAP Programs, HIV Patients--AHF Protest AIDS Healthcare Foundation
📢 Published on 📅 9 September 2025 🕒 7:00 am
Gilead dives into ‘in vivo’ cell therapy with $350M buyout of Interius - BioPharma Dive
Gilead dives into ‘in vivo’ cell therapy with $350M buyout of Interius BioPharma Dive
📢 Published on 📅 21 August 2025 🕒 7:00 am
Message from the General Manager - Gilead Sciences
Message from the General Manager Gilead Sciences
📢 Published on 📅 12 August 2025 🕒 4:54 pm
Gilead Employees Give Back During Month of Service - Gilead Sciences
Gilead Employees Give Back During Month of Service Gilead Sciences
📢 Published on 📅 31 July 2025 🕒 7:00 am
Attorney General Schwalb Recovers Over $300,000 from Gilead Sciences for Illegal Kickback Scheme - District of Columbia | Attorney General (.gov)
Attorney General Schwalb Recovers Over $300,000 from Gilead Sciences for Illegal Kickback Scheme District of Columbia | Attorney General (.gov)
📢 Published on 📅 15 July 2025 🕒 7:00 am
Gilead: 2025 TIME100 Most Influential Companies - Time Magazine
Gilead: 2025 TIME100 Most Influential Companies Time Magazine
📢 Published on 📅 26 June 2025 🕒 7:00 am
